Fig. 5From: Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathologyAssociations of plasma biomarkers with cognitive performance across the total study cohort, presented as standardized effect sizes with 95% confidence intervals of age, sex, and education (according to Verhage (1965) system)Â adjusted linear regression analysis between plasma biomarker levels and cognitive domain scores. Plasma Abeta(1-42/1-40) levels were inverted prior to analysis, so that the direction of effect sizes are comparable for all markers. Abeta, amyloid beta; GFAP, glial fibrillary acidic protein; NfL, neurofilament lightBack to article page